Most recently, targeted RNA interference (RNAi) technology has been used to inhibit anthrax toxin intoxication through silencing ANTXR1 and/or ANTXR2 in mouse and human macrophages [55]. This evidence concerns the gene ANTXR2 and anthrax infection.